(Q52197571)

26 April 2018

title

The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus. (English)

1 reference

26 April 2018

1 reference

Helsley S

1

1 reference

26 April 2018

Rabin RA

series ordinal

2

1 reference

26 April 2018

Winter JC

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

26 April 2018

published in

Life Sciences

1 reference

26 April 2018

volume

60

1 reference

26 April 2018

issue

9

1 reference

26 April 2018

page(s)

PL147-53

1 reference

26 April 2018

Effects and aftereffects of ibogaine on morphine self-administration in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Inhibitory effects of ibogaine on cocaine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

A preliminary investigation of ibogaine: case reports and recommendations for further study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Ibogaine-like effects of noribogaine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Radioligand-binding study of noribogaine, a likely metabolite of ibogaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900703-5

10.1016/S0024-3205(96)00703-5

7 January 2021

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018